+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Life Science Analytics Software Market by Product, Application, Delivery Model and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • ID: 5118769
  • Report
  • April 2020
  • Region: Global
  • 289 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Accenture Plc
  • ArisGlobal LLC
  • Certara L.P.
  • Clarivate Analytics Plc
  • Dassault Systemes
  • IQVIA Holdings Inc.
The global life science analytics software market size in 2019 was $5.35 billion in 2019, and is expected to reach $16.04 billion by 2027 at a CAGR of 12.3% from 2020 to 2027.The life sciences industry is moving from treatment to preventive scenarios and management of patient's health outcomes. In addition, early detection of disease patterns and strategic target is the key for effective business strategies. Thus, life science companies are demanding for analytics software that is used to transform data into useful insights. In addition, benefits of analytics software in life sciences such as early detection of prescription and treatment patterns, strategizing patient outcomes and achieving better operational quality that drives the intellectual journey of patient centricity further boosts the growth of the global life science analytics software market.



The market is derived completely on the basis of the revenue generated through software license, subscription and maintenance. These are used in research & development, clinical trials, preclinical trials, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The major factors driving the growth of the life science analytics software is rise in in prevalence of chronic disease; and pressure to reduce healthcare expenditure and increased demand for improved patient outcomes. In addition, increase in adoption of analytics solutions in clinical trials and sales & marketing applications further boosts market growth. However, lack of skilled professionals in developing countries and data privacy issues hamper market growth. On the contrary, emergence of big data analytics to increase R&D productivity is anticipated to provide significant profitable opportunities for manufacturers in the life science analytics software industry.

The life science analytics software market is segmented on the basis of product, application, delivery model, end user and region. By product, it is divided into descriptive analytics, prescriptive analytics and predictive analytics. On the basis of application, it is classified into research & development, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The research & development is further segmented into clinical trials and preclinical trials. On the basis of delivery model, it is bifurcated into on-premise and cloud. By end user, it is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers and third-party administrators (TPAS). Region wise, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global life science analytics software market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment
  • The market forecast is studied from 2020 to 2027
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

KEY MARKET SEGMENTS

By Product
  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

By Application
  • Research and Development
  • Clinical Trials
  • Preclinical Trials
  • Sales and Marketing Support
  • Regulatory Compliance
  • Supply Chain Analytics
  • Pharmacovigilance

By Delivery
  • On-Premise
  • Clouds

By End User
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third Party Administrators (TPAS)

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe

KEY MARKET PLAYERS
  • Accenture Plc,
  • ArisGlobal LLC,
  • Chemical Abstracts Services (ACS)
  • Certara, L.P
  • Clarivate Analytics Plc.
  • Cognizant Technology Solutions Corporation
  • Dassault Systemes
  • Deloitte Touche Tohmatsu Limited.
  • IQVIA Holdings Inc
  • Microsoft Corporation
  • Oracle Corporation
  • TIBCO Software Inc.
  • Veeva Systems Inc.

The other players in the value chain include (profiles not included in the report):
  • IBM Corporation
  • Quintiles Inc
  • SAS Institute Inc.
  • SCIO Health Analytics
  • TAKE Solution
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accenture Plc
  • ArisGlobal LLC
  • Certara L.P.
  • Clarivate Analytics Plc
  • Dassault Systemes
  • IQVIA Holdings Inc.

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models
1.4.4. Primary Research
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2019
3.3. Porter’S Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Surge in Prevalence of Chronic Disease
3.4.1.2. Pressure to Reduce Healthcare Expenditure & Increased Demand for Improved Patient Outcomes.
3.4.1.3. Rise in Adoption of Analytics Solutions in Clinical Trials and Sales & Marketing Applications
3.4.2. Restraints
3.4.2.1. Lack of Skilled Professionals in Developing Countries
3.4.2.2. Data Privacy Issues
3.4.3. Opportunity
3.4.3.1. Emergence of Big Data Analytics to Increase R&D Productivity
Chapter 4: Global Life Science Analytics Software Market, by Product
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Descriptive Analytics
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.3. Predictive Analytics
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Analysis, by Country
4.4. Prescriptive Analytics
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Analysis, by Country
Chapter 5: Global Life Science Analytics Software Market, by Application
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Research and Development
5.2.1. Market Size and Forecast, by Type
5.2.1.1. Clinical Trials
5.2.1.1.1. Market Size and Forecast
5.2.1.2. Preclinical Trials
5.2.1.2.1. Market Size and Forecast
5.2.2. Market Size and Forecast, by Region
5.2.3. Market Analysis, by Country
5.3. Sales and Marketing Support
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Regulatory Compliance
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country
5.5. Supply Chain Analytics
5.5.1. Market Size and Forecast, by Region
5.5.2. Market Analysis, by Country
5.6. Pharmacovigilance
5.6.1. Market Size and Forecast, by Region
5.6.2. Market Analysis, by Country
Chapter 6: Global Life Science Analytics Software Market, by Delivery Model
6.1. Overview
6.1.1. Market Size and Forecast
6.2. On-Premise
6.2.1. Market Size and Forecast, by Region
6.2.2. Market Analysis, by Country
6.3. Cloud
6.3.1. Market Size and Forecast, by Region
6.3.2. Market Analysis, by Country
Chapter 7: Global Life Science Analytics Software Market by End-user
7.1. Overview
7.1.1. Market Size and Forecast
7.2. Pharmaceutical and Biotechnology Companies
7.2.1. Market Size and Forecast, by Region
7.2.2. Market Analysis, by Country
7.3. Medical Device Companies
7.3.1. Market Size and Forecast, by Region
7.3.2. Market Analysis, by Country
7.4. Research Centers
7.4.1. Market Size and Forecast, by Region
7.4.2. Market Analysis, by Country
7.5. Third-Party Administrators
7.5.1. Market Size and Forecast, by Region
7.5.2. Market Analysis, by Country
Chapter 8: Life Science Analytics Software Market, by Region
8.1. Overview
8.1.1. Market Size and Forecast
8.2. North America
8.2.1. Key Market Trends, Growth Factors and Opportunities
8.2.2. North America Life Science Analytics Software Market, by Country
8.2.2.1. U. S. Life Science Analytics Software Market, by Product
8.2.2.2. U. S Life Science Analytics Software Market, by Application
8.2.2.3. U. S. Life Science Analytics Software Market, by Delivery Model
8.2.2.4. U. S. Life Science Analytics Software Market, by End-user
8.2.2.5. Canada Life Science Analytics Software Market, by Product
8.2.2.6. Canada Life Science Analytics Software Market, by Application
8.2.2.7. Canada Life Science Analytics Software Market, by Delivery Model
8.2.2.8. Canada Life Science Analytics Software Market, by End-user
8.2.2.9. Mexico Life Science Analytics Software Market, by Product
8.2.2.10. Mexico Life Science Analytics Software Market, by Application
8.2.2.11. Mexico Life Science Analytics Software Market, by Delivery Model
8.2.2.12. Mexico Life Science Analytics Software Market, by End-user
8.2.3. North America Life Science Analytics Software Market, by Product
8.2.4. North America Life Science Analytics Software Market, by Application
8.2.5. North America Life Science Analytics Software Market, by Delivery Model
8.2.6. North America Life Science Analytics Software Market, by End-user
8.3. Europe
8.3.1. Key Market Trends, Growth Factors and Opportunities
8.3.2. Europe Life Science Analytics Software Market, by Country
8.3.2.1. UK Life Science Analytics Software Market, by Product
8.3.2.2. UK Life Science Analytics Software Market, by Application
8.3.2.3. UK Life Science Analytics Software Market, by Delivery Model
8.3.2.4. UK Life Science Analytics Software Market, by End-user
8.3.2.5. Germany Life Science Analytics Software Market, by Product
8.3.2.6. Germany Life Science Analytics Software Market, by Application
8.3.2.7. Germany Life Science Analytics Software Market, by Delivery Model
8.3.2.8. Germany Life Science Analytics Software Market, by End-user
8.3.2.9. France Life Science Analytics Software Market, by Product
8.3.2.10. France Life Science Analytics Software Market, by Application
8.3.2.11. France Life Science Analytics Software Market, by Delivery Model
8.3.2.12. France Life Science Analytics Software Market, by End-user
8.3.2.13. Italy Life Science Analytics Software Market, by Product
8.3.2.14. Italy Life Science Analytics Software Market, by Application
8.3.2.15. Italy Life Science Analytics Software Market, by Delivery Model
8.3.2.16. Italy Life Science Analytics Software Market, by End-user
8.3.2.17. Spain Life Science Analytics Software Market, by Product
8.3.2.18. Spain Life Science Analytics Software Market, by Application
8.3.2.19. Spain Life Science Analytics Software Market, by Delivery Model
8.3.2.20. Spain Life Science Analytics Software Market, by End-user
8.3.2.21. Rest of Europe Life Science Analytics Software Market, by Product
8.3.2.22. Rest of Europe Life Science Analytics Software Market, by Application
8.3.2.23. Rest of Europe Life Science Analytics Software Market, by Delivery Model
8.3.2.24. Rest of Europe Life Science Analytics Software Market, by End-user
8.3.3. Europe Life Science Analytics Software Market, by Product
8.3.4. Europe Life Science Analytics Software Market, by Application
8.3.5. Europe Life Science Analytics Software Market, by Delivery Model
8.3.6. Europe Life Science Analytics Software Market, by End-user
8.4. Asia-Pacific
8.4.1. Key Market Trends, Growth Factors and Opportunities
8.4.2. Asia-Pacific Life Science Analytics Software Market, by Country
8.4.2.1. Japan Life Science Analytics Software Market, by Product
8.4.2.2. Japan Life Science Analytics Software Market, by Application
8.4.2.3. Japan Life Science Analytics Software Market, by Delivery Model
8.4.2.4. Japan Life Science Analytics Software Market, by End-user
8.4.2.5. China Life Science Analytics Software Market, by Product
8.4.2.6. China Life Science Analytics Software Market, by Application
8.4.2.7. China Life Science Analytics Software Market, by Delivery Model
8.4.2.8. China Life Science Analytics Software Market, by End-user
8.4.2.9. Australia Life Science Analytics Software Market, by Product
8.4.2.10. Australia Life Science Analytics Software Market, by Application
8.4.2.11. Australia Life Science Analytics Software Market, by Delivery Model.
8.4.2.12. Australia Life Science Analytics Software Market, by End-user
8.4.2.13. India Life Science Analytics Software Market, by Product
8.4.2.14. India Life Science Analytics Software Market, by Application
8.4.2.15. India Life Science Analytics Software Market, by Delivery Model
8.4.2.16. India Life Science Analytics Software Market, by End-user
8.4.2.17. Rest of Asia-Pacific Life Science Analytics Software Market, by Product
8.4.2.18. Rest of Asia-Pacific Life Science Analytics Software Market, by Application
8.4.2.19. Rest of Asia-Pacific Life Science Analytics Software Market, by Delivery Model
8.4.2.20. Rest of Asia-Pacific Life Science Analytics Software Market, by End-user
8.4.3. Asia-Pacific Life Science Analytics Software Market, by Product
8.4.4. Asia-Pacific Life Science Analytics Software Market, by Application
8.4.5. Asia-Pacific Life Science Analytics Software Market, by Delivery Model
8.4.6. Asia-Pacific Life Science Analytics Software Market, by End-user
8.5. LAMEA
8.5.1. Key Market Trends, Growth Factors and Opportunities
8.5.2. LAMEA Life Science Analytics Software Market, by Country
8.5.2.1. Brazil Life Science Analytics Software Market, by Product
8.5.2.2. Brazil Life Science Analytics Software Market, by Application
8.5.2.3. Brazil Life Science Analytics Software Market, by Delivery Model
8.5.2.4. Brazil Life Science Analytics Software Market, by End-user
8.5.2.5. Saudi Arabia Life Science Analytics Software Market, by Product
8.5.2.6. Saudi Arabia Life Science Analytics Software Market, by Application
8.5.2.7. Saudi Arabia Life Science Analytics Software Market, by Delivery Model
8.5.2.8. Saudi Arabia Life Science Analytics Software Market, by End-user
8.5.2.9. South Africa Life Science Analytics Software Market, by Product
8.5.2.10. South Africa Life Science Analytics Software Market, by Application
8.5.2.11. South Africa Life Science Analytics Software Market, by Delivery Model
8.5.2.12. South Africa Life Science Analytics Software Market, by End-user
8.5.2.13. Rest of LAMEA Life Science Analytics Software Market, by Product
8.5.2.14. Rest of LAMEA Life Science Analytics Software Market, by Application
8.5.2.15. Rest of LAMEA Life Science Analytics Software Market, by Delivery Model
8.5.2.16. Rest of LAMEA Life Science Analytics Software Market, by End-user
8.5.3. LAMEA Life Science Analytics Software Market, by Product
8.5.4. LAMEA Life Science Analytics Software Market, by Application
8.5.5. LAMEA Life Science Analytics Software Market, by Delivery Model
8.5.6. LAMEA Life Science Analytics Software Market, by End-user
Chapter 9: Company Profiles
9.1. Accenture plc
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.2. Arisglobal LLC
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Key Strategic Moves and Developments
9.3. Chemical Abstracts Services (Acs)
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.4. Certara, L. P.
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Key Strategic Moves and Developments
9.5. Clarivate Analytics plc
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.5.5. Business Performance
9.5.6. Key Strategic Moves and Developments
9.6. Cognizant Technology Solutions Corporation
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Business Performance
9.6.6. Key Strategic Moves and Developments
9.7. Dassault Systemes
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments:
9.7.4. Product Portfolio
9.7.5. Business Performance
9.8. Deloitte
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.8.5. Business Performance
9.9. Iqvia Holdings Inc
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.9.5. Business Performance
9.9.6. Key Strategic Moves and Developments
9.10. Microsoft Corporation
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
9.10.5. Business Performance
9.11. Oracle Corporation
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Operating Business Segments
9.11.4. Product Portfolio
9.11.5. Business Performance
9.11.6. Key Strategic Moves and Developments
9.12. Tibco Software Inc
9.12.1. Company Overview
9.12.2. Operating Business Segments
9.12.3. Product Portfolio
9.13. Veeva Systems Inc
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Operating Business Segments
9.13.4. Product Portfolio
9.13.5. Business Performance
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accenture Plc
  • ArisGlobal LLC
  • Certara L.P.
  • Clarivate Analytics Plc
  • Dassault Systemes
  • IQVIA Holdings Inc.
According to the report titled, 'life science analytics software market by of product, application, delivery model and end user: opportunity Analysis and Industry Forecast, 2020-2027,”

The global life science analytics software market size was valued at $5.35 billion in 2019 and is expected to reach $16.04 billion by 2027 with a CAGR of 12.3% during the forecast period.

The life sciences industry is moving from treatment to preventive scenarios and management of patient's health outcomes. In addition, early detection of disease patterns and strategic target is the key for effective business strategies. Thus, life science companies are demanding for analytics software that is used to transform data into useful insights. Further, benefits of analytics software in life sciences such as early detection of prescription and treatment patterns, strategizing patient outcomes and achieving better operational quality that drives the intellectual journey of patient centricity further boosts the growth of the global life science analytics software market.

The need for improved data standardization and rises in utilization of analytics software, coupled with increase in incidences of chronic diseases boost the life science analytics software market growth. However, data privacy issues and lack of skilled professionals for big data solutions restrict the market growth. Moreover, emergence of social media and its impact on the life science industry offers lucrative opportunities for key market players operating in the analytics software segment.

In additional, such analytics capabilities develop the performance of pharmaceutical manufacturing so that they can deliver safe, effective drugs and other treatment to patients with greater efficiency and assurance. The major applications of analytics software in the life science industry include research & development, clinical trials, sales and marketing support and regulatory compliance. The software helps to beat challenges in data integration and enhance operational efficiency. Furthermore, the integration of artificial intelligence (AI) and machine learning approaches within the life science industry is making drug discovery and development more inventive, time-effective and cost-effective. Thus, enhance the demand for life science analytics software market.

By product, the predictive analytics segment is expected to grow with a highest CAGR from 2020 to 2027, as the software helps to enhance the accuracy of diagnosis & treatment, as well as epidemiology to review possible risk factors for public health. This increase the demand for predictive analytics software to improve patient care and it is expected to be high in the future.

On the basis of application, the sales & marketing segment is expected to grow at the highest CAGR during the forecast period. The is attributed to the rise in adoption of analytics by life science companies to align their sales & marketing campaigns. Surge in importance of post-marketing surveillance also propels the utilization of analytics for sales & marketing in the life science industry.

Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to the surge in prevalence of chronic diseases, growth of the life science industry, rise in adoption of advanced technologies, and growth in focus of major players on increasing their presence in emerging countries

The life science analytics software market is segmented on the basis of product, application, delivery model, end user and region. By product, it is divided into descriptive analytics, prescriptive analytics and predictive analytics. On the basis of application, it is classified into research & development, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The research & development is further segmented into clinical trials and preclinical trials. On the basis of delivery model, it is bifurcated into on-premise and cloud. By end user, it is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers and third-party administrators (TPAS). Region wise, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.

The report provides a Some of the key players operating in the life science analytics software market include Accenture Plc, ArisGlobal LLC, Chemical Abstracts Services(ACS), Certara, L.P., Clarivate Analytics Plc, Cognizant Technology Solutions Corporation, Dassault Systemes, Deloitte ToucheTohmatsu Limited, IQVIA Holdings Inc., Microsoft Corporation, Oracle Corporation, TIBCO Software Inc.,andVeeva Systems Inc.

Key Findings Of The Study

Based on type, the descriptive analytics segment accounted for the largest life science analytics software market share in 2019.
Based on application, sales & marketing segment is expected to grow at the highest CAGR during the forecast period
In 2019, North America held the major share of the life science analytics software market.
By delivery model, cloud based software of life science analytics is expected to grow at the highest CAGR.
Note: Product cover images may vary from those shown
  • Accenture Plc
  • ArisGlobal LLC
  • Chemical Abstracts Services(ACS)
  • Certara L.P.
  • Clarivate Analytics Plc
  • Cognizant Technology Solutions Corporation
  • Dassault Systemes
  • Deloitte ToucheTohmatsu Limited
  • IQVIA Holdings Inc.
  • Microsoft Corporation
  • Oracle Corporation
  • TIBCO Software Inc.
  • Veeva Systems In
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...